Advertisement

Topics

Bavarian Nordic Announces Initiation of NCI-sponsored Phase 2 Study of PROSTVAC in Patients with Localized Prostate Cancer

03:31 EDT 24 Jul 2015 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Multi-center, placebo-controlled study designed to explore PROSTVAC® in patients undergoing active surveillance  COPENHAGEN, Denmark - July 24, 2015 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the first patient has been enr...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Bavarian Nordic Announces Initiation of NCI-sponsored Phase 2 Study of PROSTVAC in Patients with Localized Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...